PRKCD and hepatocellular carcinoma: The consequence of flow cytometric analysis demonstrated that the activation level of platelets was significantly reduced after stimulation by PRKCD-silencing HCC cells compared with the negative control (HCC cells transfected with si-NC), implying that PRKCD in tumor cells may influence platelet activation, while the specific molecular mechanism still needs to be further investigated.